Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014

International Journal of Environmental Research and Public Health
Karen BissellGlobal Asthma Network Study Group

Abstract

Patients with asthma need uninterrupted supplies of affordable, quality-assured essential medicines. However, access in many low- and middle-income countries (LMICs) is limited. The World Health Organization (WHO) Non-Communicable Disease (NCD) Global Action Plan 2013⁻2020 sets an 80% target for essential NCD medicines' availability. Poor access is partly due to medicines not being included on the national Essential Medicines Lists (EML) and/or National Reimbursement Lists (NRL) which guide the provision of free/subsidised medicines. We aimed to determine how many countries have essential asthma medicines on their EML and NRL, which essential asthma medicines, and whether surveys might monitor progress. A cross-sectional survey in 2013⁻2015 of Global Asthma Network principal investigators generated 111/120 (93%) responses-41 high-income countries and territories (HICs); 70 LMICs. Patients in HICs with NRL are best served (91% HICs included ICS (inhaled corticosteroids) and salbutamol). Patients in the 24 (34%) LMICs with no NRL and the 14 (30%) LMICs with an NRL, however no ICS are likely to have very poor access to affordable, quality-assured ICS. Many LMICs do not have essential asthma medicines on their EML or NRL. Technical...Continue Reading

References

May 28, 2003·Lancet·Richard LaingEllen 't Hoen
Feb 25, 2009·Thorax·C K W LaiUNKNOWN International Study of Asthma and Allergies in Childhood Phase Three Study Group
Nov 16, 2010·Bulletin of the World Health Organization·S K PerehudoffH V Hogerzeil
Dec 15, 2010·Respiratory Medicine·Jesper Rømhild DavidsenMorten Andersen
Nov 24, 2012·Health Policy and Planning·Maryam BigdeliWim Van Damme
Jan 17, 2014·The Lancet. Respiratory Medicine·Neil PearceDavid Strachan
Mar 29, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J Mark FitzGerald, Mohsen Sadatsafavi
Feb 15, 2015·The Lancet. Respiratory Medicine·David BeranUNKNOWN Forum of International Respiratory Societies working group collaboration
May 8, 2015·Globalization and Health·Jane RobertsonDavid Beran
Mar 21, 2013·Public Health Action·G AdeC-Y Chiang
Sep 21, 2013·Public Health Action·A I El SonyD A Enarson
Nov 26, 2015·Lancet·Andy L GrayHans V Hogerzeil
Dec 10, 2015·PloS One·Mai DuongUNKNOWN World Hospital Pharmacy Research Consortium (WHoPReC)
May 9, 2016·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·K BissellD Beran
Jun 15, 2016·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Gina EomJacalyn Duffin
Nov 12, 2016·Lancet·Veronika J WirtzMichael R Reich
Nov 16, 2016·Journal of Pharmaceutical Policy and Practice·Raffaella RavinettoJean-Michel Caudron
Apr 13, 2017·CMAJ Open·Michael S TaglioneNav Persaud
Sep 7, 2018·Global Public Health·S Katrina PerehudoffHans V Hogerzeil
Dec 17, 2018·The Lancet. Respiratory Medicine·Innes AsherDavid Strachan

❮ Previous
Next ❯

Citations

Sep 29, 2020·Tropical Medicine & International Health : TM & IH·Obianuju B OzohDavid Beran
Nov 25, 2020·Pediatric Clinics of North America·Paulo Camargos, Kimberly Danieli Watts
Nov 21, 2020·Journal of Clinical Medicine·Philippa Ellwood On Behalf Of The Gan Phase I Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.